What’s new in the recent ESC Guidelines on valvular heart disease

ESC webinar

Tuesday 20 November 2012

20/11/2012 00:00 20/11/2012 00:00 Europe/Paris What’s new in the recent ESC Guidelines on valvular heart disease European Society of Cardiology contact@escardio.org DD/MM/YYYY

Topic(s):

Valvular Heart Disease

Online
event

Watch the webinar recording

Case based discussion on patients with valve disease with reference to the new ESC/EACTS guidelines

Learning objectives

To understand what is new in the 2012 ESC/EACTS guidelines on valve disease
To explain the decision making process in patients with valve disease
To demonstrate the usefulness of the “Heart team” in the management of patients with valve disease

Key references
The new ESC on EACTS guidelines
Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?
Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease).
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-2198.
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-1607.
Tribouilloy C, Lévy F, Rusinaru D, Guéret P, Petit-Eisenmann H, Baleynaud S, Jobic Y, Adams C, Lelong B, Pasquet A, Chauvel C, Metz D, Quéré JP, Monin JL. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol 2009;53:1865-1873.
Bouleti C, Iung B, Laouénan C, Himbert D, Brochet E, Messika-Zeitoun D, Détaint D, Garbarz E, Cormier B, Michel PL, Mentré F, Vahanian A. Late results of percutaneous mitral commissurotomy up to 20 years. Development and validation of a risk score predicting late functional results from a series of 912 patients. Circulation 2012 (in press)
Van de Veire NR, Braun J, Delgado V, Versteegh MI, Dion RA, Klautz RJ, Bax JJ. Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair. J Thorac Cardiovasc Surg 2011;141:1431-1439.
Unger P, Rosenhek R, Dedobbeleer C, Berrebi A, Lancellotti P. Management of multiple valve disease. Heart 2011;97:272-277

Organised by

Address

European Society of Cardiology

European Heart House
Les Templiers
2035 Route des Colles
CS 80179 Biot

06903, Sophia Antipolis, FR

Tel.
+33.4.92.94.76.00

Show navigation Hide navigation

What’s new in the recent ESC Guidelines on valvular heart disease

ESC webinar

Watch the webinar recording

Learning objectives

Organised by

Support